Eckert & Ziegler AG: 20% Growth in Revenues, 37% in Earnings
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Preliminary Results/Development of Sales
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
Berlin, 6 March 2007 – Based on preliminary calculations (unaudited) Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for medical and industrial radiation products, increased its 2006 annual revenue from 41.8 mm EUR by 8.6 mm EUR to 50.4 mm EUR and its earnings per share from 0.51 EUR to 0.70 EUR. During the last quarter of 2006, revenues topped 14.4 mm EUR, a new record and an increase of 16% over last years forth quarter value (12.4 mm EUR).
The operating income before expenses for discontinued products (SpondylAT®) more than doubled from 2.5 mm EUR to 5.9 mm EUR. EBIT from continuing operations increased from 4.3 to 5.7 mm EUR, the EBITDA from continuing operations from 8.2 to 10.3 mm EUR. A reduction of debt lead to an increase in the equity ratio from 52 to 56%.
Details on the 2006 numbers and the projections for 2007 will be presented together with the audited report at the annual press conference in Berlin on 29 March 2007.
For further questions please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany
Phone: +49 (0) 30 / 94 10 84-138,, Fax -112
www.ezag.de
DGAP 06.03.2007
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG Robert-Rössle-Str. 10
13125 Berlin Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
www: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices:
Listed: Geregelter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin-Bremen, München, Hamburg, Düsseldorf
End of News DGAP News-Service